Pro Medicus Limited
PME
Κατάταξη σε μετοχές
#1598
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Τιμή μετοχής
$129.30
Κεφαλαιοποίηση
$13.51B
Αλλαγή (1 ημέρα)
-0.17%
Αλλαγή (1 έτος)
-30.83%
Χώρα
AU
Εμπόριο Pro Medicus Limited (PME)
Κατηγορία
Healthcare
Έσοδα για την Pro Medicus Limited (PME)
Έσοδα τον Jun 2026 TTM: $184.56M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Pro Medicus Limited, τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $184.56M. Το 2024, η εταιρεία είχε έσοδα $107.79M αύξηση σε σχέση με τα έσοδα του έτους 2023, τα οποία ήταν $83.22M. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την Pro Medicus Limited από 2000 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $184.56M | 31.68% |
| 2025 | $140.16M | 30.03% |
| 2024 | $107.79M | 29.52% |
| 2023 | $83.22M | 29.09% |
| 2022 | $64.46M | 26.65% |
| 2021 | $50.90M | 29.82% |
| 2020 | $39.21M | 11.42% |
| 2019 | $35.19M | 32.27% |
| 2018 | $26.60M | 9.34% |
| 2017 | $24.33M | 18.68% |
| 2016 | $20.50M | 52.25% |
| 2015 | $13.47M | 0.06% |
| 2014 | $13.46M | 32.04% |
| 2013 | $10.19M | -11.85% |
| 2012 | $11.56M | -22.81% |
| 2011 | $14.98M | -7.87% |
| 2010 | $16.26M | 102.15% |
| 2009 | $8.04M | -8.44% |
| 2008 | $8.78M | -17.50% |
| 2007 | $10.65M | 26.89% |
| 2006 | $8.39M | 7.33% |
| 2005 | $7.82M | 42.49% |
| 2004 | $5.49M | -10.08% |
| 2003 | $6.10M | 6.64% |
| 2002 | $5.72M | 12.69% |
| 2001 | $5.08M | 0.00% |
| 2000 | 0.00 | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $20.24B | 10,867.98% |
US
|
|
| $14.37B | 7,686.76% |
US
|
|
| $1.43B | 675.89% |
US
|
|
| $616.91M | 234.25% |
US
|
|
| - | - |
US
|
